Moderna
MRNA
#1676
Rank
ยฃ7.26 B
Marketcap
ยฃ18.79
Share price
1.68%
Change (1 day)
-77.75%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

EPS for Moderna (MRNA)

EPS in 2023 (TTM): -ยฃ7.37

According to Moderna 's latest financial reports the company's current EPS (TTM) is -ยฃ6.83. In 2022 the company made an earnings per share (EPS) of ยฃ15.79 a decrease over its 2021 EPS that were of ยฃ22.64.

EPS history for Moderna from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-ยฃ7.37-146.68%
2022ยฃ15.79-30.25%
2021ยฃ22.64-1660.82%
2020-ยฃ1.4525.16%
2019-ยฃ1.1637.04%
2018-ยฃ0.85

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-ยฃ1.26-81.51%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.36-119.93%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ2.27-66.85%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ3.07-55.03%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ2.80-140.92%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-ยฃ1.27-81.40%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ10.53-254.11%๐Ÿ‡บ๐Ÿ‡ธ USA